Business
Vorasidenib, aprobat de FDA pentru pacienţii cu gliom de gradul 2, cu mutaţii IDH. Terapia dublează supravieţuirea fără progresia bolii - Raportul de gardă
By: Google News
- Aug 29 2024
- 0
- 0 Views
Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!
Easy Branches
34/17 Moo 3 Chao fah west Road, Phuket, Thailand, PhuketCall: 076 367 766
info@easybranches.com